Tumor Biology

, Volume 36, Issue 5, pp 3693–3701 | Cite as

Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer

  • Guibin Zhao
  • Lijie Liu
  • Tianshu Zhao
  • Shoude Jin
  • Sibo Jiang
  • Shouqiang Cao
  • Jingquan Han
  • Yanzhong Xin
  • Qing Dong
  • Xian Liu
  • Jian Cui
Research Article


Recent studies have implied that aberration of miR-24 is linked to various human cancers. However, its role in non-small cell lung cancer (NSCLC) remains obscure. Here, we found that miR-24 was significantly upregulated in NSCLC tissues and patients’ serum. High expression of miR-24 in patients’ serum was independently correlated with a shorter overall survival of NSCLC patients. Depletion of miR-24 inhibited cell proliferation and anchorage-independent survival ability in lung cancer cell lines and reduced tumor formation ability in nude mice. Nuclear apoptosis-inducing factor 1 (NAIF1) was identified to be a functional target of miR-24 in the human lung. Next, we observed that the NAIF1 mRNA expression level in NSCLC tissues was suppressed in comparison to that in adjacent normal tissues. Restoration of NAIF1 in lung cancer cell inhibited cell proliferation and anchorage-independent survival ability, which were found to be similar with those from transfecting a miR-24 inhibitor into lung cancer cells. In conclusion, our study demonstrated that miR-24 was upregulated in NSCLC, and suppressing the expression of miR-24 inhibited tumor characteristics. MiR-24 acted as an oncomir, at least partially through regulation of its functional target NAIF1 in NSCLC. MiR-24 may serve as a novel potential biomarker for NSCLC diagnosis and prognosis.


NSCLC Nuclear apoptosis-inducing factor 1 Mir-24 Tumorigenesis Biomarker 



This work was supported in part by the Harbin Science and Technology Bureau (grant 2012RFQGJ183, Xian Liu).

Conflicts of interest

There are no known conflicts of interest associated with this paper.

Supplementary material

13277_2014_3008_MOESM1_ESM.tif (127 kb)
Supplementary Fig. 1 a. Analysis of luciferase activity. A549 cells which have high endogenous miR-24 expression were cotransfected with firefly luciferase reporter containing 3′UTRs of interested genes, and Renilla luciferase expression construct (as an internal control). Luciferase activity was assayed 24 h after transfection. Firefly luciferase values, normalized for Renilla luciferase, are presented. The data represent the mean ± SE of four independent experiments done in duplicates. b. Western blot analysis of KSR2, FGF11, NAIF1, and β-actin in A549 cell extracts transfected with U6-miR-24 TuD plasmid. (TIFF 126 kb)


  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8:93–103.CrossRefPubMedGoogle Scholar
  4. 4.
    He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network—another piece in the tumour-suppression puzzle. Nat Rev Cancer. 2007;7:819–22.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefPubMedGoogle Scholar
  6. 6.
    Guo Y, Fu W, Chen H, Shang C, Zhong M. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol Rep. 2012;27:1097–103.PubMedGoogle Scholar
  7. 7.
    Le HB, Zhu WY, Chen DD, He JY, Huang YY, Liu XG, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol. 2012;29:3190–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 2009;37:e43.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Cao ZA, Daniel D, Hanahan D. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer. 2002;2:11.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010;251:499–505.CrossRefPubMedGoogle Scholar
  13. 13.
    Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A. 2008;105:3903–8.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008;7:759–64.CrossRefPubMedGoogle Scholar
  15. 15.
    Li J, Song Y, Wang Y, Luo J, Yu W. MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem. 2013;380:277–82.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhao WY, Wang Y, An ZJ, Shi CG, Zhu GA, Wang B, et al. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem Biophys Res Commun. 2013;435:466–71.CrossRefPubMedGoogle Scholar
  17. 17.
    Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci. 2013;126:1440–53.CrossRefPubMedGoogle Scholar
  18. 18.
    Chen L, Zhang A, Li Y, Zhang K, Han L, Du W, et al. MiR-24 regulates the proliferation and invasion of glioma by ST7L via beta-catenin/Tcf-4 signaling. Cancer Lett. 2013;329:174–80.CrossRefPubMedGoogle Scholar
  19. 19.
    Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46:204–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Zaidi SK, Dowdy CR, van Wijnen AJ, Lian JB, Raza A, Stein JL, et al. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res. 2009;69:8249–55.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Papadimitriou E, Vasilaki E, Vorvis C, Iliopoulos D, Moustakas A, Kardassis D, et al. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-beta and miR-24: role in epithelial-to-mesenchymal transition. Oncogene. 2012;31:2862–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Lv B, Shi T, Wang X, Song Q, Zhang Y, Shen Y, et al. Overexpression of the novel human gene, nuclear apoptosis-inducing factor 1, induces apoptosis. Int J Biochem Cell Biol. 2006;38:671–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Luo Q, Zhao M, Zhong J, Ma Y, Deng G, Liu J, et al. NAIF1 is down-regulated in gastric cancer and promotes apoptosis through the caspase-9 pathway in human MKN45 cells. Oncol Rep. 2011;25:1117–23.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Guibin Zhao
    • 1
  • Lijie Liu
    • 2
  • Tianshu Zhao
    • 3
  • Shoude Jin
    • 2
  • Sibo Jiang
    • 4
  • Shouqiang Cao
    • 1
  • Jingquan Han
    • 1
  • Yanzhong Xin
    • 1
  • Qing Dong
    • 1
  • Xian Liu
    • 5
  • Jian Cui
    • 1
  1. 1.Department of Thoracic Surgery, The Fourth Affiliated HospitalHarbin Medical UniversityHarbinPeople’s Republic of China
  2. 2.Respiratory Medicine Department, The Fourth Affiliated HospitalHarbin Medical UniversityHarbinPeople’s Republic of China
  3. 3.Neurosurgery Department, The Fourth Affiliated HospitalHarbin Medical UniversityHarbinPeople’s Republic of China
  4. 4.Department of PharmaceuticsUniversity of FloridaOrlandoUSA
  5. 5.Cardiology Department, The Fourth Affiliated HospitalHarbin Medical UniversityHarbinPeople’s Republic of China

Personalised recommendations